Carlsmed, Inc. Common Stock (CARL) is a publicly traded Healthcare sector company. As of July 22, 2026, CARL trades at $11.05 with a market cap of $312.63M and a P/E ratio of -5.02. CARL moved -3.96% today. Year to date, CARL is -10.77%; over the trailing twelve months it is flat. Its 52-week range spans $8.50 to $17.19. Analyst consensus is strong buy with an average price target of $18.40. Rallies surfaces CARL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CARL shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $11.05 |
| Market Cap | $312.63M |
| P/E Ratio | -5.02 |
| EPS | $-2.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.19 |
| 52-Week Low | $8.50 |
| Volume | 84.80K |
| Avg Volume | 0 |
| Revenue (TTM) | $56.44M |
| Net Income | $-32.60M |
| Gross Margin | 75.89% |
5 analysts cover CARL: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.40.